Profectus Presents Preclinical Data Demonstrating that a Single Dose of Multi-Component Vaccine Provides Complete ...PR Newswire via Yahoo! FinanceNov 17 05:30 AM
BALTIMORE, Nov. 17, 2015 /PRNewswire/ -- Profectus BioSciences, Inc., a clinical-stage vaccine company developing innovative vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced the results of preclinical data demonstrating that a single dose of a multi-component vaccine based on the company's VesiculoVax™ vector platform provides complete ...
- Science DailyOct 31 11:37 AM
A new study showed that blocking a calcium-signaling pathway could inhibit not only the Ebola virus, but also Marburg, Lassa and Junin viruses, all sources of deadly infections.
Blocking calcium-signaling pathway could inhibit... - News-Medical-Net
- EurekAlert!Oct 30 09:48 AM
( University of Pennsylvania ) A new study led by researchers at the University of Pennsylvania School of Veterinary Medicine showed that blocking a calcium-signaling pathway could inhibit not only the Ebola virus, but also Marburg, Lassa and Junin viruses, all sources of deadly infections.
- Baltimore SunNov 17 07:54 PM
A single vaccine Profectus BioSciences is developing to protect against two strains of the Ebola virus and a third similar pathogen is effective at preventing those diseases in monkeys, the Baltimore biotechnology company said Tuesday. The findings mean the vaccine could be ready for human trials...
- Marketwired via Yahoo! FinanceNov 12 06:00 AM
GeoVax Labs, Inc. , a biotechnology company developing human vaccines for HIV, Ebola virus and other infectious diseases using its novel platform technology, announced its financial results for the three ...
- Marketwired via Yahoo! FinanceNov 19 06:00 AM
GeoVax Labs, Inc. - On December 1, individuals and organizations across the globe will observe World AIDS Day 2015. GeoVax plans to commemorate the day by celebrating the progress made toward the development ...
- KPRC Local 2 HoustonNov 15 10:06 PM
Investigators from the United States Department of Agriculture are expected to visit the University of Texas Medical Branch this month to discuss treatment of monkeys.
- MarketwireNov 12 07:29 AM
ATLANTA, GA--(Marketwired - Nov 12, 2015) - GeoVax Labs, Inc. ( OTCQB : GOVX ), a biotechnology company developing human vaccines for HIV, Ebola virus and other infectious diseases using its novel platform technology, announced its financial results for the three and nine months ended September 30, 2015.
- MarketwireNov 19 11:10 AM
World AIDS Day International Theme: "Getting to Zero"; GeoVax Brings Attention to the United States HIV Epidemic and the Need for a Vaccine
- related to marburg virus